PMID:19188590 in melanomas, correlation between MIR182 expression and progression from primary to metastatic melanoma, anticorrelation with FOXO3 level. FOXO3 over-expression inhibits MIR182 metastatic effect FOXO3 is a direct target of MIR182 BIM downregulated by MIR182 supposedly through FOXO3 inhibition